0000000001021162

AUTHOR

C. Leiva

showing 2 related works from this author

Nova metodologia d'aprenentatge autònom aplicada a una pràctica d'Enginyeria Química mitjançant tècniques de recerca-acció

2014

Un grup de professors del Departament d'Enginyeria Química i Ambiental de l'Escola Tècnica Superior d'Enginyeria de la Universitat de Sevilla ha realitzat un treball d'investigació-acció amb l’objectiu de millorares resultats docents en l'assignatura Experimentació en Enginyeria Química. El procés d'investigació-acció ha consistit en dissenyar una metodologia alternativa per a una de les pràctiques de l'assignatura, incorporant un exercici d'auto-aprenentatge que substitueixi la tradicional metodologia aplicada. L'objectiu de l'experiència docent pretén aconseguir una participació més activa de l'alumnat, millorant l'assimilació de conceptes i la capacitat per planejar el treball experiment…

Investigación-acción experimentación en Ingeniería Química auto-aprendizaje trabajo autónomolcsh:Llcsh:L7-991lcsh:Education (General)lcsh:Educationaction research Chemical Engineering Laboratory self-learning autonomous work
researchProduct

A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

2021

Background: Safinamide modulates both dopaminergic and glutamatergic systems with positive effects on motor and non-motor symptoms of Parkinson's disease (PD). The drug utilization study SYNAPSES was designed to investigate the use of safinamide in routine clinical practice, as recommended by the European Medicines Agency. Objective: To describe the occurrence of adverse events in PD patients treated with safinamide in real-life conditions. Methods: The SYNAPSES trial is an observational, European, multicenter, retrospective-prospective cohort study. Patients were followed up to 12 months with analyses performed in the overall population and in patients aged >75 years, with relevant comorbi…

Research ReportMale0301 basic medicineBenzylaminesParkinson's diseaseOutcome AssessmentParkinson's diseaseComorbidityDiseaseReal-life evaluationchemistry.chemical_compound0302 clinical medicineOutcome Assessment Health Care80 and overMAO-B inhibitorAged 80 and overSafinamideeducation.field_of_studyAlanineMental DisordersParkinson DiseaseMiddle AgedMAO-B inhibitor; Parkinson's disease; Real-life evaluation; Safinamide; Aged; Aged 80 and over; Alanine; Benzylamines; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Retrospective Studies; Outcome Assessment Health CareEuropeSettore MED/26 - NEUROLOGIAFemaleErratumCohort studymedicine.medical_specialtyMonoamine Oxidase InhibitorsDrug-Related Side Effects and Adverse ReactionsPopulationMEDLINE03 medical and health sciencesCellular and Molecular NeuroscienceSafinamideInternal medicinemedicineHumansAdverse effecteducationAgedRetrospective Studiesbusiness.industryMAO-B inhibitor; Parkinson's disease; Real-life evaluation; Safinamidemedicine.diseaseHealth Care030104 developmental biologychemistryParkinson’s diseaseObservational studyNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up StudiesJournal of Parkinson's Disease
researchProduct